Edwards Lifesciences Corporation
EW
$85.28
-$1.90-2.18%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.06% | 1.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.06% | 1.36% | |||
| Cost of Revenue | -0.64% | 0.23% | |||
| Gross Profit | 1.55% | 1.69% | |||
| SG&A Expenses | 16.83% | 2.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -14.40% | 41.31% | |||
| Total Operating Expenses | 6.17% | 2.42% | |||
| Operating Income | -12.49% | -1.35% | |||
| Income Before Tax | -74.05% | -12.94% | |||
| Income Tax Expenses | -53.30% | -12.75% | |||
| Earnings from Continuing Operations | -78.04% | -12.98% | |||
| Earnings from Discontinued Operations | 1,450.00% | 54.55% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -100.00% | -52.94% | |||
| Net Income | -68.67% | -12.64% | |||
| EBIT | -12.49% | -1.35% | |||
| EBITDA | -10.68% | -1.00% | |||
| EPS Basic | -68.45% | -12.28% | |||
| Normalized Basic EPS | 4.87% | 10.89% | |||
| EPS Diluted | -69.25% | -11.72% | |||
| Normalized Diluted EPS | 4.79% | 10.86% | |||
| Average Basic Shares Outstanding | -0.74% | -0.39% | |||
| Average Diluted Shares Outstanding | -0.67% | -0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||